Verona Pharma starts Asthma drug trial – Proactive Investors UK


Proactive Investors UK

Verona Pharma starts Asthma drug trial
Proactive Investors UK
Verona Pharma (LON:VRP) has begun a new clinical trial to evaluate higher dosing of its key asthma drug, RPL554. The trial will help Verona set the dosage

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *